Guide for patients & caregivers
What Does My TPMT Test Result Mean Before Azathioprine?
TPMT test results before azathioprine explained: what normal, intermediate and low results mean, where NUDT15 fits in, why blood tests continue and what to ask.
Prepared with AI assistance and checked against the cited sources. No independent clinician review has been completed. How we prepare articles
What does a TPMT test result mean?
A TPMT test result shows how active your thiopurine methyltransferase (TPMT) enzyme is, or which versions of the TPMT gene you carry. This enzyme helps break down thiopurine medicines such as azathioprine, mercaptopurine and thioguanine. A normal result suggests usual breakdown; an intermediate or low result suggests a higher chance of side effects on the bone marrow, so the prescriber plans treatment with that in mind.
This guide covers the result itself. It cannot tell you whether azathioprine is right for you or what dose you need; those decisions belong to your prescribing team. Low blood counts during treatment are covered in our separate guides on a low white blood cell count and a low neutrophil count.
Symptoms that need urgent care on azathioprine
Whatever your TPMT result, some symptoms need prompt attention once treatment has started. The NHS advises: "Call 999 if: you're taking azathioprine and think you might be having anaphylaxis or a severe skin reaction." Anaphylaxis can cause a swollen throat or tongue, a raised itchy rash or difficulty breathing.
NHS Specialist Pharmacy Service guidance says patients should seek urgent medical attention for signs that could suggest bone marrow or liver problems, including:
- a high fever or a severe flu-like illness
- unexplained bleeding or bruising
- new yellowing of the skin or the whites of the eyes (jaundice)
- sore throat, chills or other signs of infection, unusual tiredness, pale skin or shortness of breath, which MedlinePlus lists as reasons to call your doctor straight away
Why is TPMT tested before azathioprine?
Azathioprine is an immunosuppressant used for conditions such as Crohn's disease, ulcerative colitis, rheumatoid arthritis and lupus, and after organ transplants. One possible complication of thiopurine medicines is damage to the bone marrow, which makes blood cells. MedlinePlus Genetics explains that this can happen to anyone taking these medicines, but people with TPMT deficiency are at the highest risk.
The TPMT enzyme helps turn thiopurines into inactive compounds. If the enzyme works poorly, active drug products can build up and suppress the bone marrow, which can lower red cells, white cells and platelets. That is why UK monitoring guidance lists a TPMT assay among the checks before starting, alongside a full blood count and liver and kidney tests. Arthritis UK also describes the TPMT blood test as part of the routine before azathioprine is prescribed.
Normal, intermediate, low: what do the results mean?
Labs report TPMT in different ways. An enzyme activity test gives a measured level with the lab's own categories, while a genotype test reports which gene versions were found. Cut-off numbers differ between labs, so read your result against the range or category printed on your report.
In broad terms, based on MedlinePlus Genetics and NHS guidance:
- Normal (two usual-activity gene copies): no increased risk of thiopurine-related bone marrow toxicity from TPMT, although other causes of side effects remain possible.
- Intermediate (one usual and one low-activity copy): moderately reduced activity and a higher risk of side effects. Guidance describes this as usually leading to a lower dose, decided by the prescriber.
- Low or absent (two low-activity copies, called TPMT deficiency): the highest risk. NHS pharmacy guidance says people with absent activity should not receive thiopurines, and Arthritis UK says the doctor will discuss other options if the result is very low.
How common is a low or intermediate TPMT result?
MedlinePlus Genetics reports that less than 1 percent of people have TPMT deficiency, and about another 11 percent have moderately reduced activity. NHS England's genomics education service notes that frequencies vary across ethnic groups, with up to 1 in 300 people carrying two no-function TPMT variants.
Because TPMT activity is inherited, a genotype result usually stays relevant for life. NHS genomics guidance suggests recording it in your medical summary so that other prescribers can see it.
What is NUDT15 and why might it be tested too?
NUDT15 is a second enzyme that helps inactivate thiopurine drug products. NHS England's genomics guidance explains that variants in either TPMT or NUDT15 can raise the risk of serious side effects, including severe bone marrow suppression, and that a person's overall metaboliser status is worked out from both genes.
The same source says TPMT deficiency is the main genetic cause of thiopurine intolerance in people of European and African descent, while NUDT15 variation explains most thiopurine-related bone marrow suppression in people of Asian ancestry and is also common in Hispanic populations. Up to 1 in 100 people may carry two no-function NUDT15 variants.
Testing access varies. In the NHS, TPMT and NUDT15 genetic testing is available for some leukaemia treatment, but for other conditions it is not routinely funded. Some people already have results from trials, other health systems or private tests. Standard genetic tests may also miss rarer variants, so a normal genotype is not a complete guarantee.
Do I still need blood tests if my TPMT is normal?
Yes. A normal TPMT result lowers one known risk but does not remove all of them. Arthritis UK explains that azathioprine can affect the blood count and liver, so blood tests are needed before and during treatment. NHS pharmacy guidance advises clinicians to watch trends as well as single values, because a gradual fall in white cells or a rise in liver enzymes can matter even while results are still in range.
Other factors also affect risk. MedlinePlus notes that some medicines can increase the chance of low blood counts on azathioprine, including ACE inhibitors, trimethoprim and sulfamethoxazole, and ribavirin. Tell every prescriber and pharmacist that you take azathioprine.
Do not stop or change a prescribed medicine, or its dose, because of a test result without talking to the prescriber. The NHS advice on azathioprine is to keep taking your medicine unless you're advised to stop.
Questions to ask your clinician
These questions can help you understand your own result:
- Was my test an enzyme activity test or a genotype test, and which category am I in?
- Was NUDT15 checked, and does it matter for me?
- How does this result change the treatment plan you are suggesting?
- How often will I need blood tests, and who will tell me the results?
- Which symptoms should make me call you or seek urgent care?
- Will this result be added to my records so other doctors can see it?
How SameCase can help you prepare
On SameCase, patients and verified doctors share de-identified cases. Reading how others with a similar TPMT result discussed their treatment plan can help you prepare clearer questions for your own team. We cannot interpret your result or recommend treatment, and other people's cases may not match yours. Your prescriber's advice comes first.
Sources and further reading
- MedlinePlus Genetics: Thiopurine S-methyltransferase deficiency
- NHS England Genomics Education (GeNotes): Thiopurines and pharmacogenomics
- NHS England Genomics Education (GeNotes): Known TPMT and/or NUDT15 genotype, non-malignant indications
- NHS Specialist Pharmacy Service: Azathioprine monitoring (updated January 2026)
- NHS: Azathioprine (reviewed October 2026)
- Arthritis UK: Azathioprine
- MedlinePlus: Azathioprine drug information
For patients & caregivers
Share your case and learn from others
Learn from doctors and other people's cases to find a way forward with your health problem. New cases are public immediately. Don't add names or identifying details.